Article
Treatment for hepatitis B in patients with drug resistance
1 Sept 2016
Abstract excerpt
Persistent hepatitis B virus (HBV) infections affect about 240 million patients worldwide that are at risk of developing liver cirrhosis or hepatocellular carcinoma. HBV is a small, partially double stranded DNA virus with four overlapping genes and a unique life cycle, which involves the generation of an RNA template for replication via reverse transcription. Mutations occur frequently during chronic infection,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
